Edition:
United Kingdom

Coloplast A/S (COLOb.CO)

COLOb.CO on Copenhagen Stock Exchange

636.60DKK
22 Oct 2018
Change (% chg)

kr.-6.60 (-1.03%)
Prev Close
kr.643.20
Open
kr.641.40
Day's High
kr.647.20
Day's Low
kr.634.80
Volume
215,901
Avg. Vol
285,352
52-wk High
kr.716.60
52-wk Low
kr.474.30

Latest Key Developments (Source: Significant Developments)

Coloplast Q3 EBIT DKK 1.27 Billion, Below Expectations
Wednesday, 8 Aug 2018 

Aug 8 (Reuters) - Coloplast A/S ::REG-ANNOUNCEMENT NO. 5/2018 - INTERIM FINANCIAL REPORT, 9M 2017/18.DELIVERED 8% ORGANIC REVENUE GROWTH IN Q3 OF 2017/18 FINANCIAL YEAR.Q3 RESTRUCTURING COSTS AMOUNTED TO DKK 21M COMPARED WITH DKK 3M LAST YEAR,.SAYS WE NOW EXPECT ORGANIC REVENUE GROWTH OF ABOUT 8%, UP FROM PREVIOUSLY 7-8%.Q3 REVENUE DKK 4.23 BILLION (REUTERS POLL DKK 4.25 BILLION).CAPITAL EXPENDITURE IS STILL EXPECTED TO BE AROUND DKK 700M.Q3 REVENUE DKK Q3 RESTRUCTURING COSTS AMOUNTED TO DKK 21M COMPARED WITH DKK 3M LAST YEAR BILLION (REUTERS POLL DKK 4.25 BILLION).Q3 EBIT DKK 1.27 BILLION (REUTERS POLL DKK 1.32 BILLION).EXPECTATIONS FOR LONG-TERM PRICE PRESSURES, OF ABOUT 1% IN ANNUAL PRICE PRESSURE, ARE UNCHANGED..CONTINUE TO EXPECT AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES AND A REPORTED EBIT MARGIN OF AROUND 31% IN DKK.  Full Article

Coloplast Acquires SAS Lilial
Monday, 18 Dec 2017 

Dec 18 (Reuters) - Coloplast ::ANNOUNCEMENT NO. 13/2017 - COLOPLAST A/S ACQUIRES SAS LILIAL.TO ACQUIRE SAS LILIAL FOR A CASH CONSIDERATION OF EUR 35.5M EQUAL TO APPROX. DKK 264M ON A CASH AND DEBT-FREE BASIS​.‍TRANSACTION IS SUBJECT TO CUSTOMARY CLOSING CONDITIONS, AND IS EXPECTED TO CLOSE BEFORE YEAR-END 2017​.‍ACQUISITION WILL, IF COMPLETED, LEAD TO A REVISED FINANCIAL GUIDANCE FOR FINANCIAL YEAR 2017/18​.‍LILIAL IS EXPECTED TO RECORD SALES OF APPROX. EUR 33M OR APPROX. DKK 246M FOR FULL-YEAR 2017​.  Full Article

Coloplast CFO Buys 18,693 Shares In Company For Dkk 5,448,261.78‍​
Monday, 11 Dec 2017 

Dec 11 (Reuters) - Coloplast ::CFO BUYS 18,693 SHARES IN COMPANY FOR DKK 5,448,261.78‍​.  Full Article

Coloplast sees 2017/2018 revenue growth at lower end of long-term outlook
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - COLOPLAST :Q4 REVENUE DKK 3.98‍​ BILLION (REUTERS POLL DKK 4.02 BILLION).Q4 PRETAX PROFIT DKK ‍​1.33 BILLION (REUTERS POLL DKK 1.34 BILLION).‍EXPECT ORGANIC REVENUE GROWTH OF C7% AT CONSTANT EXCHANGE RATES.Q4 EBIT DKK ‍​1.32 BILLION (REUTERS POLL DKK 1.32 BILLION).‍EXPECTS IN 2017/2018 AN EBIT MARGIN OF 31-32% AT CONSTANT EXCHANGE RATES​.‍IN 2017/2018 CAPITAL EXPENDITURE IS EXPECTED TO BE ABOUT DKK 700M AND EFFECTIVE TAX RATE IS EXPECTED TO BE ABOUT 23%​.‍RECOMMENDS TO APPROVE A YEAR-END DIVIDEND OF DKK 10.5 PER SHARE.​.‍INTENDS TO PURSUE INORGANIC GROWTH OPPORTUNITIES TO FURTHER STRENGTHEN ITS SERVICE OFFERING TO CONSUMER​.COLOPLAST - LONG-TERM ‍ORGANIC REVENUE GROWTH GUIDANCE IS MAINTAINED AT 7-9% P.A. WHERE AMBITION IS TO REACH UPPER END OF INTERVAL​.COLOPLAST - LONG-TERM, ‍EBIT MARGIN GUIDANCE REVISED FROM 50-100BP IMPROVEMENT P.A., TO EBIT MARGIN OF >30% AT CONSTANT CURRENCIES​.  Full Article

Coloplast CEO sells 117,260 shares in the company
Tuesday, 13 Dec 2016 

Coloplast : CEO sells 117,260 shares at 454.85 Danish crowns per share .Ado Holding Af 26.2.2004 aps, related party to CEO Lars Rasmussen, purchased shares worth 53,335,711.00 Danish crowns ($7.6 million).  Full Article

Photo

Trade war dents European shares while M&A boosts Sky, Randgold

LONDON The U.S.-China trade war dented European stocks on Monday after tariffs from the world's biggest economies came into force and China cancelled planned talks, triggering new fears of a protracted, costly trade dispute.